je.st
news
Tag: life sciences
Why life sciences attracts more venture funding than biotech in Seattle
2015-04-29 01:06:13| Biotech - Topix.net
A recent national report found Washington state's biotech venture capital funding faltering in early 2015. But that report doesn't tell the full story.
Tags: life
sciences
funding
seattle
Allied Minds' Subsidiary SciFluor Life Sciences Raises $30 Million...
2015-04-23 05:48:27| Biotech - Topix.net
Allied Minds , an innovative U.S. science and technology development and commercialization company, today announced that its subsidiary company, SciFluor Life Sciences, has raised $30 million. Proceeds will be used to accelerate its two lead compounds - one a topical treatment for retinal diseases and the second a treatment for neurological diseases - while expanding its drug discovery and commercialization pipeline.
Tags: life
million
sciences
life sciences
Data Collection Software meets healthcare, life sciences needs.
2015-04-20 14:31:08| Industrial Newsroom - All News for Today
Providing infrastructure for supporting data-driven transformations, Alloy Health Platform™ can aggregate and harmonize data from diverse sources to foster integration and management across interdependent domains of healthcare, health research, and life sciences. Focusing on data to support usage even as application landscape changes, solution offers purpose-specific registries, customizable tools for extraction/transformation, and real-time exposure of relevant data to authorized users.
Tags: data
software
life
collection
Insider Buying: ProMetic Life Sciences insider Buys 10,200 Shares of Stock
2015-04-12 05:51:24| Biotech - Topix.net
ProMetic Life Sciences insider Bruce Pritchard bought 10,200 shares of ProMetic Life Sciences stock on the open market in a transaction that occurred on Tuesday, April 7th. The stock was purchased at an average cost of C$2.74 per share, for a total transaction of C$27,943.92.
Tags: life
stock
buying
sciences
Emmaus Life Sciences To Present Phase 3 Sickle Cell Disease Clinical Trial Data
2015-04-01 07:37:14| drugdiscoveryonline Home Page
Emmaus Life Sciences, Inc., a biopharmaceutical company dedicated primarily to the discovery, development and commercialization of innovative treatments and therapies for rare and orphan diseases recently announced that data from the Company’s Phase 3 clinical trial of its pharmaceutical grade L-glutamine (PGLG) treatment for sickle cell anemia and sickle beta-0 thalassemia, will be presented, during the 9th Annual Sickle Cell Disease Research and Educational Symposium and 38th National Sickle Cell Disease Scientific Meeting
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] next »